Chamber and committees

The lead investigators on the 9 projects funded through the long term effects of COVID-19 infection call were notified on 22nd December 2020 that their projects had been successful in obtaining funding.

Provisional funding letters were issued in January 2021, with the start of transfer of funds as per the payment profile dependent on the receipt by the Chief Scientist Office of a Start Certificate issued by the host institution Finance Office.

Start certificates were returned for all 9 projects, with confirmation of start dates for individual projects of between 01-02-21 and 01-05-2021.

Post award monitoring is through 6 and 12 month progress reports. In addition, a final report for each project is to be submitted on completion of the project. These final reports will be made publicly available on the Chief Scientist Office website.

The end dates for the 9 projects are:

COV/LTE/20/04 HUNT

28.02.2023

COV/LTE/20/06 PELL

28.02.2023

COV/LTE/20/08 SCULTHORPE

31.03.2023

COV/LTE/20/10 BERRY

31.01.2023

COV/LTE/20/15 SHEIKH

28.02.2023

COV/LTE/20/26 CARSON

31.03.2023

COV/LTE/20/28 LINDSAY

31.01.2023

COV/LTE/20/29 COOPER/DUNCAN

30.04.2023

COV/LTE/20/32 TORRANCE/GRANT

28.02.2023

For reference, details of the 9 above projects are available from the Chief Scientist Office website

Long Covid Call – Chief Scientist Office (scot.nhs.uk)

The Scottish Government has embraced artificial intelligence (AI) as a transformational technology for public good. We were the first UK country to establish an AI Strategy which set out our ambition for Scotland to become a global exemplar in the ethical and innovative deployment of AI.

As part of the Recovery Plans for the NHS, social care and the economy, the Government will support innovation in health care delivery and the adoption of AI solutions into use. Accelerating the adoption of new technologies that support improved access to healthcare, such as the use of artificial intelligence, will be integral to the recovery of NHS services, and there are a range of partner organisations that are central to this work, including the new national Centre for Sustainable Delivery.

There is a range of projects being undertaken in Scotland to explore the use of AI in further high-demand medical areas, ranging from robotic surgery to the use of virtual reality in supporting mental wellbeing is currently being researched, evaluated, and implemented in Scotland.

The Industrial Centre for Artificial Intelligence Research in Digital Diagnostics (iCAIRD) website provides more information:

iCAIRD – Industrial Centre for Artificial Intelligence Research in Digital Diagnostics .

The amount spent on executive search, advertising and assessment centre costs for the Director General Net Zero role is £26,837. Three candidates were shortlisted and assessed. Two candidates were interviewed by the final panel.

The list of private providers is owned by the UK Government. All providers included on the list must complete or be working towards full United Kingdom Accreditation Service accreditation. If a provider does not complete this or fails the accreditation then they are removed from the list.

Officials continue to work with UK Government to monitor performance of private tests providers. This is done at the private testing provider working group with the Department of Health and Social Care and the devolved administrations, which meet every 2 weeks.

The providers have various standards to meet, which are defined in our regulations and the key performance indicators (KPIs) that are set on turnaround times, customer service and sequencing requirements. Any provider not achieving these standards or engaging in unethical practices are removed from the list.

If individuals are having or have had an issue with a private test provider, they should first report this back to the provider. If they are not satisfied with this then they can submit a complaint here: https://enquiries.test-and-trace.nhs.uk/s/enquiries where the complaint will be investigated.

NHS Lothian has, as part of their response to the reports, sent diagnostic appointments for those children identified in the review as being of clinical concern and requiring recall. In addition, the Board is working with the British Academy of Audiology to review the Auditory Brainstem Response (ABR) recordings of all children seen by the service for ABR testing during the last five years. An agreed escalation process is in place to highlight any cases of concern on a weekly basis and those of significant concern within 24 hours.

The Board is also undertaking work to review children known to the service who have risk factors for hearing loss and, based on the outcome of each review, recall children where appropriate in line with national guidance.

NHS Lothian will continue to report to the Scottish Government on a monthly basis.

The Scottish Government’s commitment to the early diagnosis of cancer is reflected in the £44m Detect Cancer Early (DCE) Programme. The NHS Recovery Plan – published August 2021 – commits an additional £20m for the DCE Programme, to provide greater public awareness of signs and symptoms of cancer and supporting the development of optimal cancer pathways to improve earlier diagnosis rates. Research will be undertaken in the coming months to better understand the possible barriers and levers to early diagnosis that any new DCE campaigns should focus on.

An overarching DCE social marketing campaign 'Survivors' was previously developed in close consultation with the Scottish Cancer Coalition in 2018. The campaign aimed to reduce fear around cancer and empower people to take early action, be it visiting their GP practice or attending screening when invited. To coincide with the campaign, a symptom-checker tool was developed on DCE’s website (getcheckedearly.org) to raise awareness of the early signs and symptoms of cancer, including blood cancer.

The pharmacy profession and the provision of pharmaceutical services are highly regulated, overseen by the General Pharmaceutical Council (GPhC). The GPhC's role includes upholding health and safety standards for the pharmacy workforce, as well as for patients.

The Scottish Government regularly meets with Community Pharmacy Scotland, the representative body for pharmacy owners, to discuss a range of topics including workforce issues, including health and wellbeing. This year the Scottish Government has made £12m available to support the wellbeing of the pharmacist workforce. This includes £8m from the NHS Recovery Plan to provide ongoing wellbeing support for the workforce – alongside an extra £4m to provide further support to address winter pressures.

The funding supports the 24/7 National Wellbeing Helpline, our National Wellbeing Hub, Coaching for Wellbeing and the Workforce Specialist Service, alongside tailored psychological interventions for staff, providing individualised wellbeing support focusing on people’s physical and emotional needs.

The Chief Pharmaceutical Officer for Scotland in a joint letter (8 December 2021) with the leaders from the pharmacy sector, including the Royal Pharmaceutical Society (Scotland), has written to all pharmacy teams outlining the range of wellbeing support available to pharmacy teams and encouraging them to access these resources for support when needed.

The community pharmacy network is a vital part of the primary care team. The Scottish Government continues to work with Community Pharmacy Scotland and other partners to ensure not only the stability of the network but also that a balance is maintained across the whole pharmacy workforce in the hospital, community, and GP practice sectors.

The Chief Pharmaceutical Officer has committed to putting together a workforce forum which will meet in early 2022. The forum will look at the workforce challenges and bring together stakeholders from pharmacy education and pharmacy service provision to set a strategic workforce plan for the profession.

The Scottish Government is not considering the introduction of sanctions for any contractor which breaches its NHS contract at present. The National Health Service (Pharmaceutical Services) (Scotland) Regulations 2009, set out the provision of NHS pharmaceutical services and requirements for those entered on the Boards Pharmaceutical List.

The Achieving Excellence in Pharmaceutical Care strategy, published in 2017, commits the Scottish Government to review contractual arrangements and as such may consider the introduction of sanctions as part of any future strategy framework.